Vivanza Biosciences Ltd

Vivanza Biosciences Annual General Meeting

Vivanza Biosciences has convened its 44th AGM on September 11, 2026 via VC/OAVM. Nine agenda items cover financial statements, director appointments, and borrowing limit approvals.

Vivanza Biosciences Annual Report

Vivanza Biosciences Limited has scheduled its 44th Annual General Meeting for September 11, 2026. The company also released its full Annual Report for the financial year 2025-26.

Vivanza Biosciences Board Meeting Outcome

Vivanza Biosciences approved its annual reports, the convening of the 44th AGM, and various procedural resolutions including borrowing limits and related party transactions for upcoming periods.

Vivanza Biosciences Board Meeting Date

Vivanza Biosciences has scheduled a board meeting for August 17, 2026, to discuss the AGM, financial reports, and various corporate authorizations under the Companies Act.

Vivanza Biosciences Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY

Vivanza Biosciences Ltd reported revenue from operations of ₹9.3 Cr (+4.5% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.1 Cr · +0.0% YoY

Vivanza Biosciences Board Meeting Date

Vivanza Biosciences has scheduled a board meeting on August 01, 2026, to consider and approve the standalone and consolidated financial results for the quarter ended June 30, 2026.

Vivanza Biosciences Other Announcement

Vivanza Biosciences declared that its statutory auditors issued an audit report with an unmodified opinion. This covers results for the quarter and year ended March 31, 2026.

Vivanza Biosciences Management Change

Vivanza Biosciences appointed Mr. Vishal Sureshbhai Katarmal as Company Secretary and Compliance Officer. The Board also noted a strategic agreement for a manufacturing project in Kyrgyzstan.